Northwest Biotherapeutics: Q2 Earnings Snapshot

August 10, 2022 GMT

BETHESDA, Md. (AP) _ Northwest Biotherapeutics Inc. (NWBO) on Tuesday reported a loss of $29.7 million in its second quarter.

The Bethesda, Maryland-based company said it had a loss of 3 cents per share.

The cancer drug developer posted revenue of $477,000 in the period.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on NWBO at